Tenax Therapeutics：孤注一擲 (NASDAQ:TENX)
· seekingalpha.com
Tenax Therapeutics, Inc. 的口服 levosimendan 第三期 LEVEL 試驗數據是一項二元催化劑。點擊此處閱讀為何 TENX 股票被調升至「持有」評級。
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions...